Skip to main content

Table 2 Patient demographic and characteristics of patients receiving external beam chemoradiotherapy (EBCRT) with and without simultaneous integrated boost (SIB) to radiologically positive lymph nodes

From: High dose simultaneous integrated boost for node positive cervical cancer

 

Overall (n = 69)

EBRT with SIB (n = 23)

EBRT without SIB (n = 46)

P value

Age

    

Median (years)

53.0

40.0

61.5

 < 0.05

Range (years)

25–89

25–64

29–89

Follow up

    

Median (months)

30.9

31.5

30.2

0.52

Range (months)

1.4–79.3

2.2–52.2

1.4–79.3

Histology

    

Squamous carcinoma

53 (77%)

20 (87%)

33 (72%)

0.11

Adenocarcinoma

12 (17%)

1 (4%)

11 (24%)

AdenoSquamous

4 (6%)

2 (9%)

2 (4%)

FIGO stage

    

IB

12 (17%)

2 (9%)

10 (22%)

 < 0.05

IIA

10 (15%)

2 (9%)

8 (18%)

IIB

36 (52%)

11 (48%)

25 (54%)

IIIA

1 (1%)

1 (4%)

0

IIIB

6 (9%)

5 (21%)

1 (2%)

IVA

4 (6%)

2 (9%)

2 (4%)